|
Procoagulant factor |
Main target |
Application |
Comercial names |
Characteristic |
Referencea |
Diagnostic tests |
Ecarin |
prothrombin |
Clotting time assay |
Tirofiban |
Prothrombin activator |
Moore [72] |
Textarin |
prothrombin |
Lupus anticoagulant
Factor V Leiden Disease |
|
Prothrombin activator |
Stocker [73] |
Noscarin |
prothrombin |
Factor V Leiden Disease |
|
Prothrombin activator |
Marsh and Williams [68] |
RVV-X |
FX |
Factor X deficiency
Lupus anticoagulant |
RVV-X |
Factor X activator |
Bezeaud et al. [76];
Triplett [77] |
RVV-V |
FV |
Clotting time assay
Factor V Leiden Disease |
RVV-V |
Factor V activator |
Schöni [7] |
Clinical
therapy |
Ancrod |
Fibrinogen |
Defibrinogenating agents |
Viprinex |
Thrombin-like |
Bell [64] |
Batroxobin |
Fibrinogen |
Defibrinogenating agents |
Reptilase; Defibrase |
Thrombin-like |
Bell [64]; Qin et al. [81]; Serrano [82] |
rLopap |
Prothrombin |
Bleeding reversor |
|
Prothrombin activator |
Andrade et al. [9] |
|
Fibrinogen and Factor X |
Procoagulant for hemorrhage |
Haemocoagulase |
Mixture: Thrombin-like and thromboplastin like enzyme |
McCleary and Kini [69] |